Insider Selling: Momenta Pharmaceuticals President Sells $67,966 in Stock (MNTA)
Momenta Pharmaceuticals (NASDAQ:MNTA) President Craig A. Wheeler unloaded 3,797 shares of the stock on the open market in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $17.90, for a total value of $67,966.30. Following the completion of the transaction, the president now directly owns 388,398 shares in the company, valued at approximately $6,952,324. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Shares of Momenta Pharmaceuticals (NASDAQ:MNTA) remained flat at $17.74 during during mid-day trading trading on Thursday. 811,473 shares of the company’s stock traded hands. Momenta Pharmaceuticals has a 52-week low of $11.22 and a 52-week high of $19.90. The stock has a 50-day moving average of $18.3 and a 200-day moving average of $16.68. The company’s market cap is $908.0 million.
Momenta Pharmaceuticals (NASDAQ:MNTA) last issued its quarterly earnings data on Monday, February 10th. The company reported ($0.59) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.45) by $0.14. The company had revenue of $12.80 million for the quarter, compared to the consensus estimate of $8.50 million. During the same quarter in the previous year, the company posted ($0.35) earnings per share. The company’s revenue for the quarter was up .8% on a year-over-year basis. On average, analysts predict that Momenta Pharmaceuticals will post $0.85 earnings per share for the current fiscal year.
Momenta Pharmaceuticals, Inc (NASDAQ:MNTA) is a biotechnology company specializing in the characterization and process engineering of complex molecules.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.